Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 50,000 shares at $75.94 ($3.7M) on 2019-01-31, disclosed to the SEC on 2019-02-01.
Scheduled sale ($3.7M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.01 | 3,101 | $223K | 6.0% |
| 2 | $73.12 | 10,215 | $747K | 20.1% |
| 3 | $74.20 | 11,418 | $847K | 22.8% |
| 4 | $74.64 | 266 | $20K | 0.5% |
| 5 | $73.58 | 1,808 | $133K | 3.6% |
| 6 | $74.28 | 5,364 |
| $398K |
| 10.7% |
| 7 | $75.33 | 17,673 | $1.3M | 35.9% |
| 8 | $75.94 | 155 | $12K | 0.3% |
| Total | $74.24 avg | 50,000 | $3.7M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |